ATLAS Market profile
Menu
Atlas · Symbols · Stocks & Shares · INGR

Atlas market file · Equity · United States

Ingredion IncINGR

Last close
102.93
Change
-0.35%
96-bar range
94.44 – 116.48
As of
6 Aug 2026

Ingredion Inc is a grain mill products issuer listed as INGR on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot NYSE:INGR

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

117.14111.30105.4699.619493.778820 Mar29 May06 Aug

up candle   down candle

Latest close102.93
Day change-0.35%
Window high116.48
Window low94.44
96-bar change-5.71%
SnapshotDaily · 96 bars
As of2026-08-06 13:30 UTC

Weekly outlook: the last 104 weekly closes (-22.50% over the window).

153.7195.33819 Aug06 Aug

Source rail: Yahoo Finance chart API (INGR). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for INGR. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

INGR public profile

Company

Grain mill products issuer. Ingredion Inc is connected to current market context, cited company sources and its retained research file.

Market

Ingredion Inc trades as INGR on NYSE. Ingredion Inc (INGR) has a latest verified close of 102.93, down 0.35%, dated 6 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files INGR under USA Stocks for browsing.

Institutional Market Wit ● Sourced Research File

Ingredion's latest 10-Q shows a company that can still turn starch and sugar into cash-$1.79bn of revenue in Q1 2026, a tidy $142m net profit, and $33m of operating cash flow-figures that would look respectable in any industry, let alone one where the raw materials are literally grown in fields and processed in plants. The balance sheet carries $914m in cash and equivalents, a cushion that would make most consumer-goods peers jealous, yet the footnotes reveal a $47m drawdown on inventories, a sign that even a starch giant can misjudge demand or supply chains can still hiccup. The stock trades around a valuation that rewards consistency, not hype, which makes the polished product pages and sustainability slide decks feel like window dressing rather...

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for Ingredion Inc today

Open full report
INGR daily contextvalidated public digest14 source rail2026-08-07 02:40 UTC

Ingredion Incorporated closed the books on a $1.79bn revenue quarter ending March 31 2026, a figure that would look healthy in most industries and still earns a nod in food-ingredient manufacturing-especially when net income clocks in at $142m and operating cash flow lands at $33m. The assets side of the balance sheet shows $7.93bn in total assets against $3.48bn of liabilities, leaving shareholders with $4.38bn of equity and $914m of cash on hand. Those numbers are the adult version of “we make stuff people eat,” undecorated by the clean-label buzz that now dominates the marketing site. (source: SEC EDGAR 10-Q for the quarter ended 2026-03-31, https://www.sec.gov/Archives/edgar/data/1046257/000104625726000177/xslF345X06/form10q.htm).

In plain language, Ingredion buys corn, tapioca, sugar and other plant inputs, turns them into starches, sweeteners, fibres and texturants, then sells those ingredients to food and beverage makers who need them to keep snacks crisp, yoghurts spoonable and sauces stable. The company’s Texture Equation℠ landing page promises manufacturers a “winning formula” to hit the right crunch, cream or chew, while its PureCircle clean-taste solutions page markets stevia variants for sugar reduction across beverages, fruit preps, syrups and bars. Citrus fibre pages pitch FIBERTEX™ CF as a clean-label crutch when labels must shrink and costs must not. None of this is fake; it is simply marketing, not evidence. (source: Ingredion product rails, https://www.ingredion.com/na/en-us/company/expertise/texturants/texture-equation, https://www.ingredion.com/na/en-us/ingredients/ingredient-product-families/purecircle-clean-taste-solutions, https://www.ingredion.com/na/en-us/be-whats-next/citrus-fiber-market-drives-product-improvement).

Filings show Ingredion spent $71m on R&D in the year to December 31 2025, a figure that is large in absolute terms and modest relative to revenue, while capital expenditure for the quarter was $110m. Shares outstanding on a diluted basis were 64m at March 31 2026, with diluted EPS of $2.22 for the quarter. Inventory fell by $47m during the period, an unwind that could be seasonal stocking or early evidence of softer end-market demand. The company’s sustainability pages tout a partnership with HowGood to quantify greenhouse-gas, water-use and soil-health metrics, but the 10-Q does not link any of these metrics to revenue or margin in the reported quarter. (source: SEC EDGAR 10-K 2025, 10-Q 2026-03-31, https://www.sec.gov/Archives/edgar/data/1046257/000162828026000082/xslF345X06/form10k.htm, https://www.sec.gov/Archives/edgar/data/1046257/000104625726000177/xslF345X06/form10q.htm).

For colour, the June 30 2026 8-K confirms Ingredion completed the sale of 51% of Rafhan Maize Products Co, a business that generated roughly $250m of net sales in 2025 and sits outside the reportable segments. The proceeds will bulk up cash and trim non-core exposure, but the 10-Q does not say how much cash was received or whether any gain was booked. Meanwhile, the company’s sustainability landing page is heavy on partnership claims-HowGood validation, greenhouse-gas metrics, water usage, soil health-while the 10-Q reports nothing that ties these claims to the reported quarter’s income statement. (source: SEC EDGAR 8-K 2026-06-30, https://www.sec.gov/Archives/edgar/data/1046257/000104625726000210/ingr-20260630.htm; Ingredion sustainability page, https://www.ingredion.com/na/en-us/company/meet-ingredion/sustainability/esg-strategy-solutions).

The filing rail has not parsed segment-level revenue, gross margin or cash-flow data for Q1 2026, so the source requires readers to wait for the 10-K narrative or future 10-Q disclosures to see whether the clean-label push is translating into margin expansion. Until then, the texture equations and citrus fibres remain product pitches rather than audited profit drivers. (source: SEC EDGAR filing index, https://www.sec.gov/edgar/browse/?CIK=1046257).

Sources & evidence · 10 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
INGR
Exchange
NYSE
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView

INGR technical readout

Trend strength (ADX 14)
22.2
Average true range (ATR 14)
2.3281
ATR as % of price
2.27%
Volatility compression (ATR14/ATR50)
0.97x

Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

INGR evidence rails

Atlas uses the specific public rails available for INGR: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 5 rails

Open an Atlas research path on INGR

FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for INGR Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep INGR research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

INGR FAQ

What is Ingredion Inc (INGR)?Ingredion Inc (INGR) has a latest verified close of 102.93, down 0.35%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed...

Ingredion Inc (INGR) has a latest verified close of 102.93, down 0.35%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for INGR?Ingredion Inc (INGR) has a latest verified close of 102.93, down 0.35%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks...

Ingredion Inc (INGR) has a latest verified close of 102.93, down 0.35%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files INGR under USA Stocks for browsing.

How often is the INGR page updated?The INGR public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The INGR public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for INGR?The INGR file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:INGR. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...

The INGR file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:INGR. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on INGR?Yes. The workstation can open INGR, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open INGR, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this INGR page investment advice?No. The INGR page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The INGR page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →